Zobrazeno 1 - 10
of 288
pro vyhledávání: '"Hideo Inaji"'
Autor:
Yuri Noda, Yuko Nakanishi, Ayaka Izui, Hiroyo Takahashi, Chiya Oshiro, Hideo Inaji, Masaru Yamasaki
Publikováno v:
Human Pathology: Case Reports, Vol 21, Iss , Pp 200415- (2020)
Sebaceous carcinoma (SC) is an aggressive malignancy derived from the sebaceous glands. SC is divided into two categories, ocular and extraocular. Extraocular SC is quite rare, and is also associated with the Muir-Torre syndrome, which is regarded as
Externí odkaz:
https://doaj.org/article/1e4952fae114400bb5bf08b5ae209818
Autor:
Hitoshi Tsuda, Futoshi Akiyama, Toru Watanabe, Yasuo Ohashi, Akihiko Shimomura, Nobuaki Sato, Hideo Inaji, Shozo Ohsumi, Shinji Ohno, Shigehira Saji, Yutaka Tokuda, Masafumi Kurosumi, Norikazu Masuda, Shintaro Takao
Publikováno v:
Cancer Research. 80:P2-14
Background: Two randomized controlled trials comparing the efficacy of oral tegafur-uracil (UFT) (2 years) with that of classical cyclophosphamide, methotrexate, and fluorouracil (CMF) (6 courses) were conducted in patients with resected early breast
Autor:
Shinji Ohno, Futoshi Akiyama, Akihiko Shimomura, Shintaro Takao, Toru Watanabe, Shozo Ohsumi, Yasuo Ohashi, Hitoshi Tsuda, Shigehira Saji, Nobuaki Sato, Masafumi Kurosumi, Hideo Inaji, Yutaka Tokuda, Norikazu Masuda
Publikováno v:
Breast Cancer Research and Treatment
Purpose To evaluate the efficacies of cyclophosphamide, methotrexate, and fluorouracil (CMF) and tegafur–uracil (UFT) as adjuvant therapy in patients with resected stage I–IIIA breast cancer by immunohistochemistry (IHC)-based subtype and to dete
Autor:
Shozo Ohsumi, Reiki Nishimura, Norikazu Masuda, Sadako Akashi-Tanaka, Kimito Suemasu, Hideko Yamauchi, Eriko Tokunaga, Tadashi Ikeda, Tsunehiro Nishi, Hiroto Hayashi, Yuichi Iino, Yuichi Takatsuka, Yasuo Ohashi, Hideo Inaji
Publikováno v:
Breast cancer (Tokyo, Japan).
Background Breast-conserving surgery with radiotherapy is one of standard treatments for early breast cancer. However, it is regarded as an option to treat elderly patients with small hormone receptor-positive breast cancer with breast-conserving sur
Autor:
KAHO NAKAMURA, MAKOTO ISHITOBI, CHIYA OSHIRO, HIROAKI SHIMA, ERIKO TAKAHASHI, TAKAHIRO NAKAYAMA, TADAHIKO SHIEN, KANAKO SAITO, TSUGUO IWATANI, YUKIKO SETO, KAORI TERATA, GORO KUTOMI, TOMOKO OGAWA, HIDEO INAJI
Publikováno v:
In Vivo; Mar/Apr2023, Vol. 37 Issue 2, p794-800, 7p
Autor:
Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama, Shinji Ohno, Shigehira Saji, Norikazu Masuda, Akihiko Shimomura, Nobuaki Sato, Shintaro Takao, Shozo Ohsumi, Yutaka Tokuda, Hideo Inaji, Toru Watanabe
Publikováno v:
Breast cancer (Tokyo, Japan). 29(4)
Background This retrospective observational study validated nuclear grading criteria developed to identify a high-risk group with recurrence rate ≥20–30% and local pathology diagnosis used in a previous multi-institutional randomized N·SAS-BC 01
Autor:
Tomio Nakayama, Takashi Watanabe, Hideo Inaji, Mina Takahashi, Yoshinori Ito, Shozo Ohsumi, K Yoshidome, Kazuhiko Nakagami, K Yonemori, Yutaka Tokuda, Yasuo Ohashi, Y Yamaguchi, Shintaro Takao
Publikováno v:
Cancer Research. 79:P1-13
Background: Two randomized controlled trials comparing the efficacy of oral tegafur-uracil (UFT) (2 years) with that of classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) (6 courses) were conducted in patients with resected early brea
Autor:
Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama, Shinji Ohno, Shigehira Saji, Norikazu Masuda, Akihiko Shimomura, Nobuaki Sato, Shintaro Takao, Shozo Ohsumi, Yutaka Tokuda, Hideo Inaji, Toru Watanabe
Publikováno v:
Breast Cancer. 29:730-730
Autor:
Hideo Inaji, Chiya Oshiro, Masaru Yamasaki, Yuko Nakanishi, Yuri Noda, Ayaka Nishimae, Hiroyo Takahashi
Publikováno v:
Diagnostic cytopathologyREFERENCES. 48(7)
Solid basaloid adenoid cystic carcinoma (SB-AdCC) is a subtype of breast AdCC which shows more aggressive clinical behavior than other subtypes. Fine-needle aspiration (FNA) cytology is a useful diagnostic tool for breast malignancies. However, most
Autor:
Tokuhiro Chano, Kaichiro Ikebuchi, Yasuhiko Tomita, Yufen Jin, Hideo Inaji, Makoto Ishitobi, Koji Teramoto, Yasuko Ochi, Hitosuke Tameno, Ichiro Nishimura, Kahori Minami, Hirokazu Inoue, Takahiro Isono, Masao Saitoh, Taketoshi Shimada, Yasuo Hisa, Hidetoshi Okabe
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15737 (2010)
RB1-inducible coiled-coil 1 (RB1CC1) plays a significant role in the enhancement of the retinoblastoma tumor suppressor (RB1) pathway and is involved in breast cancer development. However, RB1CC1's role in clinical progression of breast cancer has no
Externí odkaz:
https://doaj.org/article/ff4149df896f4e37a283a1c97ca267bc